Gd-EOB-DTPA-enhanced MR imaging: Evaluation of hepatic enhancement effects in normal and cirrhotic livers

Vogl, 1996, Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA, Radiology, 200, 59, 10.1148/radiology.200.1.8657946 Weinmann, 1991, A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI, Magn Reson Med, 22, 233, 10.1002/mrm.1910220214 Schuhmann-Giampieri, 1992, Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system, Radiology, 183, 59, 10.1148/radiology.183.1.1549695 Clément, 1992, Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats, Invest Radiol, 27, 612, 10.1097/00004424-199208000-00010 Kogita, 2010, Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow, Eur Radiol, 20, 2405, 10.1007/s00330-010-1812-9 Ichikawa, 2010, Invest Radiol, 45, 133, 10.1097/RLI.0b013e3181caea5b Motosugi, 2010, Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging, Radiology, 256, 151, 10.1148/radiol.10091885 Kim, 2010, Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?, Invest Radiol, 45, 740, 10.1097/RLI.0b013e3181e943a7 Huppertz, 2004, Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings, Radiology, 230, 266, 10.1148/radiol.2301020269 Hammerstingl, 2008, Diagnostic efficacy of gadoxetic acid (primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions, Eur Radiol, 18, 457, 10.1007/s00330-007-0716-9 van Montfoort, 1999, Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1, J Pharmacol Exp Ther, 290, 153 Tschirch, 2008, Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma, Eur Radiol, 18, 1577, 10.1007/s00330-008-0929-6 Tajima, 2010, Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging, J Comput Assist Tomogr, 34, 362, 10.1097/RCT.0b013e3181cd3304 Motosugi, 2009, Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?, J Magn Reson Imaging, 30, 1042, 10.1002/jmri.21956 Ito, 2004, Imaging diagnosis of cirrhosis and chronic hepatitis, Intervirology, 47, 134, 10.1159/000078465 Pieters PC, Miller WJ, DeMeo JH. Evaluation of the portal venous system: complementary roles of invasive and noninvasive imaging strategies. Radiographics; 17(4):879–95. Kim, 1997, Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA, J Magn Reson Imaging, 7, 683, 10.1002/jmri.1880070413 Mühler A, Freise CE, Kuwatsuru R, et al. Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplantation model. Radiology; 186(1):139–46. Ryeom, 2004, Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA, Korean J Radiol, 5, 231, 10.3348/kjr.2004.5.4.231 Tsuda, 2007, Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging, Invest Radiol, 42, 242, 10.1097/01.rli.0000258058.44876.a5 Kitao, 2010, Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging—correlation with molecular transporters and histopathologic features, Radiology, 256, 817, 10.1148/radiol.10092214 Geier, 2003, Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis, Hepatology, 38, 345, 10.1053/jhep.2003.50317 Geier, 2002, Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride, J Hepatol, 37, 198, 10.1016/S0168-8278(02)00108-3 Planchamp, 2005, Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers, Invest Radiol, 40, 187, 10.1097/01.rli.0000154587.00638.77 Popper, 1997, Pathologic aspects of cirrhosis, Am J Pathol, 87, 228 Ward, 2002, How to detect hepatocellular carcinoma in cirrhosis, Eur Radiol, 12, 2258, 10.1007/s00330-002-1450-y Frericks, 2009, Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA, AJR Am J Roentgenol, 193, 1053, 10.2214/AJR.08.1946 Tamada, 2009, Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA, J Magn Reson Imaging, 29, 636, 10.1002/jmri.21689 Wong, 1998, Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs, JAMA, 280, 2088, 10.1001/jama.280.24.2088 Maharaj, 1986, Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver, Lancet, 1, 523, 10.1016/S0140-6736(86)90883-4 Aguirre, 2006, Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging, Radiology, 239, 425, 10.1148/radiol.2392050505